Latest News about NVS
Recent news which mentions NVS
Exelixis' Lead Cancer Treatment Delivers Another Surprise, Though Analyst Finds Commercial Opportunity In Pancreatic Neuroendocrine Modest
August 24, 2023
From Benzinga
Cheaper Version Of Blockbuster Arthritis Treatment Humira - CVS Health Teams With Sandoz
August 24, 2023
From Benzinga
Could This Medicine Be the Next Winner for Novartis?
August 23, 2023
From Motley Fool
From Benzinga
SpaceX On Par With Intel, Disney; US Weight Loss Drugs Pricier; Moderna, Pfizer's Shot Effective Against New Variant: Today's Top Stories
August 18, 2023
From Benzinga
Merck Reveals Mixed Results From Pivotal Kidney Cancer Study Of Welireg In Pretreated Patients
August 18, 2023
From Benzinga
Novartis' Generic Business Spinoff: Plans Sandoz Spin-Off In Early October, Proposes Share Distribution
August 18, 2023
Tickers
NVS
From Benzinga
2 Excellent Stocks to Buy and Hold Forever
August 17, 2023
From Motley Fool
2 Top Biotech Stocks to Buy Right Now
August 14, 2023
From Motley Fool
3 Unstoppable Dividend Stocks to Buy Right Now
August 12, 2023
From Motley Fool
Novartis's Remibrutinib Shows Rapid Improvement In Type Of Skin Disorder That Impacts 40M People
August 09, 2023
Tickers
NVS
From Benzinga
The Year’s Top 3 International ETFs as of August 2023
August 07, 2023
From InvestorPlace
From InvestorPlace
2 Stocks That Raised Their Guidance in July
July 26, 2023
From Motley Fool
Seven Humira Biosimilars: Increased Competition In Arthritis Drug Market Sparks Need For Reform Of Drug Pricing Intermediaries
July 26, 2023
From Benzinga
From InvestorPlace
FDA Greenlights Daiichi Sankyo's Blood Cancer Drug, A Promising Competitor to Novartis' Rydapt
July 21, 2023
From Benzinga
Why Harrow Health Stock Is Trading Higher Today?
July 19, 2023
From Benzinga
From Benzinga
Why Novartis Stock Spiked Today
July 18, 2023
From Motley Fool
From Benzinga
Novartis Q2 Earnings: Company Lifts Outlook, Launches $15B Share Buyback, Maps Out Sandoz Spin-Off
July 18, 2023
Tickers
NVS
From Benzinga
Nasdaq, S&P 500 Futures Dip Ahead of Big Bank Earnings, Retail Sales Data: Why This Analyst Stays Cautious About Tech Sector
July 18, 2023
From Benzinga
From MarketWatch
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.